Rethinking Biosimilar Approval: A Future Without Phase 3 Trials?

Speaker Presentation CMC Europe 2024
Barry Sean, Health Products Regulatory Authority, 2024
Rethinking Biosimilar Approval: A Future Without Phase 3 Trials?